Navigation Links
Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results
Date:9/20/2011

and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.  The Company disclaims any obligation to update its forward-looking relationships.MISONIX, INC. And SubsidiariesConsolidated Balance SheetsJune 30, 2011June 30, 2010AssetsCurrent Assets:  Cash and cash equivalents$6,881,093$9,900,605  Accounts receivable, less allowancefor doubtful accounts of $115,739 and$123,346, respectively2,294,2542,335,653  Inventories, net3,779,0202,699,717  Prepaid expenses and other current assets374,472515,427  Note receivable210,0001,075,105Total current assets13,538,83916,526,507Property, plant and equipment, net991,195500,215Goodwill1,701,0941,701,094Other assets2,127,1941,730,339Total assets$18,358,322$20,458,155Liabilities and stockholders' equityCurrent liabilities:  Notes payable$   -$177,679  Accounts payable1,336,558888,654  Accrued expenses and other current liabilities1,969,0781,000,523Total current liabilities3,305,6362,066,856Capital lease obligations$   -14,274Deferred income161,360250,739Deferred lease liability14,043-Total liabilities3,481,0392,331,869Commitments and contingenciesStockholders' equity:  Capital stock, $0.01 par value - shares authorized
  20,000,000; 7,079,170  issued and 7,001,370 outstanding, respectively70,79270,792  Additional paid-in capital25,787,96025,502,717  Accumulated deficit(10,569,045)(7,034,799)  Treasury stock, 77,800 shares(412,424)(412,424)Stockholders' equity14,877,28318,126,286Total liabilities and stockholders' equity$18,358,322$20,458,155MISONIX, INC. And SubsidiariesConsolidated Statements of OperationsUnauditedThree Months EndedTwelve Months EndedJune 30,June 30,2011

20102011

2010Net sales

$4,165,230

'/>"/>

SOURCE Misonix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
3. Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million
4. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
5. Misonix Announces New Distribution Agreement for Mexico
6. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
7. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
8. Misonix Announces New Distribution Agreement for Peru
9. Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)
10. Misonix Announces New Distribution Agreement for Argentina
11. Misonix Announces New Distribution Agreement for Kingdom of Saudi Arabia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... DIEGO, Jan. 22, 2015  ResMed Inc. (NYSE: RMD ... 2014. Revenue for the quarter was $423.0 million, a 10 ... (a 14 percent increase on a constant currency basis). Net ... to the quarter ended December 31, 2013. Diluted earnings per ...
(Date:1/22/2015)... Jan. 22, 2015  Profil Institute for Clinical Research, Inc., ... obesity, announced today a new textbook,  Translational Research Methods ... Springer, a leading global scientific publisher. The ... techniques for use in early phase clinical studies of ...
(Date:1/22/2015)... Jan. 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/w25xpc/allergy ... Market by Allergen Source, Product & by End User - ... The global allergy diagnostics market is valued at ... a CAGR of 12.67%, to reach $2,230.72 million by 2019. ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3
... SAN DIEGO, Nov. 9, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ... September 30, 2009. , Arena reported a lower net loss allocable ... million, or $0.38 per share, compared to a net loss allocable ... million, or $0.76 per share, and a net loss allocable to ...
... Mass., Nov. 9 Groundbreaking articles in current issues ... for the first time explore, in depth, the emergence ... and its potential benefits for patients. , In these ... who is a member of the prestigious Medical Scientist ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
(Date:1/22/2015)... a new blog post presenting a list of vehicles that cannot ... Some types of vehicles cannot be covered under an ordinary auto ... see if their vehicle qualifies for auto insurance coverage. , ... that cannot be covered by a plan. Clients have little options ...
(Date:1/22/2015)... Step into a macabre world where plants hold ... Wicked Plants, the Museum’s latest featured exhibition, opens Saturday, ... and diabolical plants inside of a dilapidated, Victorian home. ... physical and neurological processes between botanicals and the human ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... Dec. 17 CareFusion Corporation (NYSE: CFN ) announced ... by TRC Capital Corporation (TRC) to purchase up to four million ... shares of common stock outstanding. TRC,s offer price of $23.50 per ... common stock on Dec. 14, 2009, the last full trading day ...
... , , HOUSTON, Dec. ... a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ... commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian ... development - the rights to which have been assigned ...
... LONDON, December 17 Researchers from the ... in the UK are today,encouraging families worldwide to take ... that shows two-thirds of people,across the globe are not walking ... likely (71%) and Austrians (63%) most likely to,walk together. , ...
... New ... family caregiver , ... (PRWEB) December 17, 2009 -- The National Alliance on Mental Illness (NAMI) praises a new ... nearly one-in-three American adults who serve as a family caregiver. , , ,The study is ...
... ... has driven these changes , ... Charlotte, N.C. (Vocus) December 17, 2009 -- Morehead, the human capital research firm, will host ... hour-long webinar will be broadcast on Wednesday, January 27, 2010 at 1:00 p.m. EST. ...
... ... like Google Local and in front of their local customers by establishing a simple ... Webtyde Internet Marketing. , ... New Orleans, LA (PRWEB) December 17, 2009 -- In order to be competitive ...
Cached Medicine News:Health News:CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 4Health News:The Family Walk - a Dying Tradition Around the World? 2Health News:NAMI Applauds New Report on Caregiving 2Health News:NAMI Applauds New Report on Caregiving 3Health News:Morehead Presents Webinar on "The State of Employee Engagement: A Year in Review" 2Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: